CYRX vs CDNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 04, 2026
CYRX
CDNA
Investment Advisor Scores
CDNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CYRX | CDNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 88.4956 | 94.3396 | CYRX |
| PEG Ratio | 62.1277 | -0.12 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 16.5% | 52.2% | CDNA |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 58.2/100 | 44.7/100 | CYRX |
| Profit Margin | 43.6% | 24.2% | CYRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CYRX
MarkupPrice above SMA50, rising 50-day trend (10.8% over 20 days), RSI 50
CDNA
MarkupPrice above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81
Fundamentals Snapshot
| Metric | CYRX | CDNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -25.0 | 37.2 |
| Trailing P/E | — | 21.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.5% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | -0.2% | 0.0% |
| EPS | -0.90 | 2.08 |
| Dividend Yield | — | — |